Hikma Names Injectables Chief Mishlawi As CEO
New Chief Replaces Interim Leader Darwazah Following Olafsson’s Departure Last Year
Hikma’s president of injectables, Riad Mishlawi, has been chosen to become the firm’s new CEO from the start of September. The move comes after a period of success in injectables for Hikma, at the same time as the firm attempts to revive the fortunes of its generics business.
